Preclinical evaluation of a novel dual acting V1a/V2 vasopressin receptor antagonist by using a noninvasive cardiac output monitor
27 May 2018 (08:30 - 18:00)
Organised by:
Abstract
About the speaker
Bayer AG, Wuppertal (Germany)
46 More presentations in this session
Access the full session
The Event
Heart Failure 2018
27 May 2018
08:30 CET
You may be interested in
Congress Presentation
Congress Session
